TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 196 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $9,783,000 | +299.1% | 130,011 | +42.4% | 0.11% | +378.3% |
| Q1 2022 | $2,451,000 | -43.6% | 91,331 | +0.2% | 0.02% | -42.5% |
| Q4 2021 | $4,346,000 | -38.2% | 91,120 | -14.0% | 0.04% | +17.6% |
| Q3 2021 | $7,038,000 | +74.3% | 105,950 | +104.7% | 0.03% | -12.8% |
| Q2 2021 | $4,038,000 | -12.7% | 51,763 | +5.8% | 0.04% | -15.2% |
| Q1 2021 | $4,628,000 | -23.2% | 48,939 | -1.0% | 0.05% | -31.3% |
| Q4 2020 | $6,023,000 | +36.9% | 49,436 | -1.8% | 0.07% | +11.7% |
| Q3 2020 | $4,398,000 | +387.0% | 50,343 | +260.5% | 0.06% | +300.0% |
| Q2 2020 | $903,000 | +97.6% | 13,964 | +36.6% | 0.02% | +66.7% |
| Q1 2020 | $457,000 | +9.1% | 10,223 | +52.2% | 0.01% | +50.0% |
| Q4 2019 | $419,000 | – | 6,715 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 708,233 | $44,116,000 | 18.91% |
| Corriente Advisors, LLC | 285,000 | $17,753,000 | 9.54% |
| Cormorant Asset Management, LP | 3,396,650 | $211,577,000 | 8.44% |
| Opaleye Management Inc. | 340,500 | $21,210,000 | 4.16% |
| Orbimed Advisors | 2,745,327 | $171,006,000 | 2.44% |
| Parkman Healthcare Partners LLC | 101,434 | $6,318,000 | 1.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,179,000 | 0.78% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 366,000 | $22,798,000 | 0.73% |
| Artal Group S.A. | 300,000 | $18,687,000 | 0.72% |
| DAFNA Capital Management LLC | 30,408 | $1,894,000 | 0.65% |